| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/15/2007 | CN101015580A pH-dependent composite bone peptide preparation, preparing method and use thereof |
| 08/15/2007 | CN101015504A Method for producing suppository for treating uterus adenomyosis |
| 08/14/2007 | US7256321 Intracellular modulators of apoptopic cell death pathways |
| 08/14/2007 | US7256284 Inhibitory oligonucleotides targeted to Bcl-2 |
| 08/14/2007 | US7256281 Recombinant P. falciparum merozoite protein-142 vaccine |
| 08/14/2007 | US7256279 Protein having ribonucleotide reductase activity and DNA thereof |
| 08/14/2007 | US7256277 Nucleotide and protein sequence of mammastatin and methods of use |
| 08/14/2007 | US7256274 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
| 08/14/2007 | US7256267 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
| 08/14/2007 | US7256265 Genetic engineered polypeptides |
| 08/14/2007 | US7256264 Receptor for IL-17 homologous polypeptides and uses thereof |
| 08/14/2007 | US7256263 High molecular weight Dermatophagoides proteins, and nucleic acids encoding them; used to treat and diagnose mite allergies |
| 08/14/2007 | US7256260 Human p53 mutations and a genetic system in yeast for functional identification of human p53 mutations |
| 08/14/2007 | US7256258 Preparing stereospecific growth hormone releasing factor (GRF) for diagnosis and treatment of growth hormone deficiencies |
| 08/14/2007 | US7256257 Pentapeptide compounds and uses related thereto |
| 08/14/2007 | US7256256 CDK4 binding peptide |
| 08/14/2007 | US7256253 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 08/14/2007 | US7256200 administering mixture of opioid and calmodulin kinase inhbitor |
| 08/14/2007 | US7256184 analyzing concentration of carbonic anhydrase isozymes in tissues, blood or cerebrospinal fluid of patients, than administering proenzymes or drugs that promotes the natural generation of the cell-specific carbonic anhydrase enzymes; aging resistance |
| 08/14/2007 | US7256176 Modulating monocyte concentrating hormone signaling in a beta cell, contacting a beta cell with an effective amount of an agonist of melanocyte concentrating hormone (MCH), wherein the agonist comprises MCH or a peptide |
| 08/14/2007 | US7256174 Administering a therapeutically effective amount of H-Cys-Phe-Phe-D-Trp-Lys-Thr-Phe-Cys-NH2, wherein a disulfide bond exists between the free thiols of two cysteine residue |
| 08/14/2007 | US7256172 Administering to animal, an amount of a peptide effective for mediating relaxation of airway, peptide is capable of activating an airway epithelium protease activated receptor-2 (PAR2) under conditions sufficient for activation of said PAR2 to occur, thereby mediating relaxation of airway |
| 08/14/2007 | US7256171 Administering to the mammal a compound that is an analog of a core 2 GlcNAc transferase acceptor substrate and inhibits the activity of the core 2 GlcNAc transferase, thereby inhibiting the inflammatory response in the mammal |
| 08/14/2007 | US7256043 Transfection complexes |
| 08/14/2007 | US7256041 Culturing mammalian cells containing a nucleic acid construct including a selectable marker operably linked to a promoter that preferentially expresses the selectable marker in mammalian stem cells; isolating mammalian stem cells expressing the selectable marker |
| 08/14/2007 | US7256039 PRO4405 nucleic acids |
| 08/14/2007 | US7256036 Blocking receptor binding; gene therapy; gastrin releasing peptide |
| 08/14/2007 | US7256034 Inhibitor of cell proliferation and methods of use thereof |
| 08/14/2007 | US7256031 Derived from filamentous fungi of the genus Acremonium; processing plants or plant-derived substances |
| 08/14/2007 | US7256020 Using rolling circle amplification of propagate and detect preferential nucleotide sequences |
| 08/14/2007 | US7256015 TALL-1 receptor molecules and uses thereof |
| 08/14/2007 | US7256010 Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, ATPase molecules, acyltransferase molecules, pyridoxal-phosphate dependant enzyme molecules and uses therefor |
| 08/14/2007 | US7256007 Methods of regulating cytokine signalling |
| 08/14/2007 | US7256004 Detecting tumor cells expressing TAG-72 using CC49 in which less than all six (three heavy chain and three light chain) Complementarity Determining Regions are present |
| 08/14/2007 | US7255997 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 08/14/2007 | US7255988 Use of α 1-antichymotrypsin polypeptides, or nucleic acids encoding them, or of a cell which is expressing an ACT polypeptide, or a nucleic acid encoding it, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds and for identifying pharmacologically active substances |
| 08/14/2007 | US7255984 Combination therapy for osteoporosis |
| 08/14/2007 | US7255887 Use of Bowman Birk inhibitor for the treatment of multiple sclerosis and other autoimmune diseases |
| 08/14/2007 | US7255872 Molecule is immobilized on the surface of a metallic or ceramic implant material. An anchor molecule (e.g., dialdehyde or cyanogen bromide) having a functional group that covalently binds the mediator molecule is covalently bound to |
| 08/14/2007 | US7255867 Group A streptococcal antigen combined with proteosome adjuvant; prevention or reduction of throat colonization; intranasal administration |
| 08/14/2007 | US7255866 Botulinum toxin therapy for fibromyalgia |
| 08/14/2007 | US7255865 Administering a Clostridium neurotoxin component using a needleless syringe to treat involunatary muscle contraction |
| 08/14/2007 | US7255863 Group A streptococcal vaccines |
| 08/14/2007 | US7255861 Preparations for inducing immunotolerance and uses therefor |
| 08/14/2007 | US7255858 Enhancing the efficacy of immunotherapies by supplementing with complement |
| 08/14/2007 | US7255857 Lysyl oxidase-like 1 (LOXL1) and elastogenesis |
| 08/14/2007 | US7255856 Lysyl oxidase-like 1 (LOXL1) and elastogenesis |
| 08/14/2007 | US7255854 Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases |
| 08/14/2007 | CA2394572C Fusion protein having enhanced in vivo activity of erythropoietin |
| 08/14/2007 | CA2240427C Growth hormone secretagogue receptor family |
| 08/14/2007 | CA2223176C Novel kappa receptor selective opioid peptides |
| 08/14/2007 | CA2166328C Prostacyclin synthase derived from human |
| 08/09/2007 | WO2007090094A2 Thermally-targeted delivery of medicaments, including doxorubicin |
| 08/09/2007 | WO2007090087A2 Use of corticotropin releasing factor receptor-2 inhibitors for treating insulin-related diseases |
| 08/09/2007 | WO2007089923A2 Modifications of cst-ii for increased protein expression |
| 08/09/2007 | WO2007089851A2 Compositions and methods for treating collagen-mediated diseases |
| 08/09/2007 | WO2007089745A2 Novel compounds with high therapeutic index |
| 08/09/2007 | WO2007089618A2 Hepatitis c serine protease inhibitors and uses therefor |
| 08/09/2007 | WO2007089454A2 Methods for enhancing skin treatments |
| 08/09/2007 | WO2007089445A2 Ang2 and vegf inhibitor combinations |
| 08/09/2007 | WO2007089272A2 Non-toxic biofilm inhibitor |
| 08/09/2007 | WO2007089151A1 Use of tlr3 agonists for the treatment of neurodegenerative disorders |
| 08/09/2007 | WO2007088830A1 Novel peptide and therapeutic agent for endotoxin-induced disease using the same |
| 08/09/2007 | WO2007088823A1 ABZYME TO HUMAN TNF-α AND USE THEREOF |
| 08/09/2007 | WO2007088712A1 Neuronal cell death inhibitor and screening method |
| 08/09/2007 | WO2007088705A1 Remedy for diabetic |
| 08/09/2007 | WO2007088651A1 JOINT USE OF TGF-β SIGNAL INHIBITOR AND ANTITUMOR AGENT |
| 08/09/2007 | WO2007088476A1 Methods for treating unwanted weight loss or eating disorders by administering a trkb agonist |
| 08/09/2007 | WO2007088418A1 Drug-eluting intravascular prostheses and methods of use |
| 08/09/2007 | WO2007088159A1 Methods of treating degenerative disorders with rac 1b inhibitor |
| 08/09/2007 | WO2007087759A2 Pharmaceutical composition of microspheres for preventing diabetic foot amputation |
| 08/09/2007 | WO2007087689A1 A method of modulating cellular activity and agents for use therein |
| 08/09/2007 | WO2007087667A2 Combination preparation for improving sperm quality |
| 08/09/2007 | WO2007073186A3 Use of c1 inhibitor for the prevention of ischemia-reperfusion injury |
| 08/09/2007 | WO2007064859A3 Compound and method for suppressing retroviral replication |
| 08/09/2007 | WO2007061850A3 Methods and systems for generating and evaluating peptides |
| 08/09/2007 | WO2007058383A3 Lipid secretion promoter containing lacritin or compound having lacritin activity |
| 08/09/2007 | WO2007053390A3 Methods for the use of branched chain amino acids |
| 08/09/2007 | WO2007050513A3 Pseudomonas aeruginosa l-d carboxypeptidase a, expression and activity |
| 08/09/2007 | WO2007045873A3 Medical uses and therapies based upon the action of azurocidin on igfbp-1 |
| 08/09/2007 | WO2007028969A3 Anchoring disruption molecules |
| 08/09/2007 | WO2007027751A3 Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins |
| 08/09/2007 | WO2007024700A3 Exendin for treating diabetes and reducing body weight |
| 08/09/2007 | WO2007021886A3 Truncated memapsin 2 for use for treating alzheimer's disease |
| 08/09/2007 | WO2007016150A3 Mutated pseudomonas exotoxins with reduced antigenicity |
| 08/09/2007 | WO2006114105A8 Use of modified factor vii for treating bleeding |
| 08/09/2007 | WO2006112550A3 A THERAPEUTIC AGENT FOR Aβ RELATED DISORDERS |
| 08/09/2007 | WO2006105315A3 Compositions and methods for regulating inflammatory responses |
| 08/09/2007 | WO2006069000A3 Klf2 as a mediator of statin activity |
| 08/09/2007 | WO2006050177A3 Antibodies that bind urokinase-type plasminogen activator and epitopes therefor |
| 08/09/2007 | WO2006042329A8 Crig polypeptide for prevention and treatment of complement-associated disorders |
| 08/09/2007 | WO2005097154A3 Neurotransmitter mixture which promotes the healing of wounds |
| 08/09/2007 | WO2004069795A3 Diagnosis and treatment of chronic tissue damage |
| 08/09/2007 | WO2004063331A3 SiRNA MEDIATED POST-TRANSRIPTIONAL GENE SILENCING OF GENES INVOLVED IN ALOPECIA |
| 08/09/2007 | US20070186311 BETA 1,2-xylosyltransferase-gene from arabidopsis |
| 08/09/2007 | US20070185348 P-selectin targeting ligand and compositions thereof |
| 08/09/2007 | US20070185315 Novel albumins |
| 08/09/2007 | US20070185314 Crystals of LuxP and complexes thereof |
| 08/09/2007 | US20070185203 Treating or preventing vascular condition in patient by administering locally a therapeutically effective amount of a composition that increases metabolic production of nitric oxide by nitric oxide synthases; treatment of glaucoma, pulmonary hypertension, asthma, chronic obstructive pulmonary disease |
| 08/09/2007 | US20070185050 Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion gene |